Pliant Therapeutics Inc (PLRX)

Pliant Therapeutics Inc Azioni (PLRX) Dati Finanziari

Conto economico

Trimestrale

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	-	-	-	0.248	1.332
Operating Expenses	11.38% 52.39	47.04	47.69	47.58	43.43
Interest Income/Expense	38.63% 0.445	0.321	0.317	0.319	0.311
Operating Income/Loss	11.38% -52.39	-47.04	-47.69	-47.33	-42.09
Income/Loss From Continuing Operations Before Tax	-46.95	-	-41.49	-41.19	-37.55
Income Tax Expense/Benefit	-	-	-	-	-
Income/Loss From Continuing Operations After Tax	14.22% -46.95	-41.11	-41.49	-41.19	-37.55
Net Income/Loss	14.22% -46.95	-41.11	-41.49	-41.19	-37.55
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	14,965% 60.18	0.3995	59.69	59.17	56.06
Diluted Average Shares	14,965% 60.18	0.3995	59.69	59.17	56.06
Basic Earnings Per Share	13.04% -0.78	-0.69	-0.70	-0.70	-0.67
Diluted Earnings Per Share	13.04% -0.78	-0.69	-0.70	-0.70	-0.67
Common Stock Dividends	-	-	-	-	-
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-